Neural Stem Cells Therapy for Ischemic Stroke: Progress and Challenges

Transl Stroke Res. 2022 Oct;13(5):665-675. doi: 10.1007/s12975-022-00984-y. Epub 2022 Jan 15.

Abstract

Ischemic stroke, with its high morbidity and mortality, is the most common cerebrovascular accident and results in severe neurological deficits. Despite advances in medical and surgical intervention, post-stroke therapies remain scarce, which seriously affects the quality of life of patients. Over the past decades, stem cell transplantation has been recognized as very promising therapy for neurological diseases. Neural stem cell (NSC) transplantation is the optimal choice for ischemic stroke as NSCs inherently reside in the brain and can potentially differentiate into a variety of cell types within the central nervous system. Recent research has demonstrated that NSC transplantation can facilitate neural recovery after ischemic stroke, but the mechanisms still remain unclear, and basic/clinical studies of NSC transplantation for ischemic stroke have not yet been thoroughly elucidated. We thus, in this review, provide a futher understanding of the therapeutic role of NSCs for ischemic stroke, and evaluate their prospects for future application in clinical patients of ischemic stroke.

Keywords: Ischemic stroke; Neural stem cells; Transplantation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Ischemia* / therapy
  • Humans
  • Ischemic Stroke*
  • Neural Stem Cells*
  • Quality of Life
  • Stem Cell Transplantation / methods
  • Stroke* / therapy